William White

CFO & Head of Corporate Development at Akero

Bill White is the Chief Financial Officer and Head of Corporate Development at Akero. Prior to joining Akero, Bill spent 18 years as a life science-focused investment banker. He was most recently head of U.S. Life Sciences Investment Banking at Deutsche Bank, and previously worked at Goldman Sachs and Citigroup. Prior to his time on Wall Street, Bill was an attorney at Sullivan & Cromwell, and a law clerk to the Honorable Kimba M. Wood of the Southern District of New York. He holds an A.B. from Princeton, M.P.P. from Harvard, and a J.D. from Columbia.

Location

New York, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Akero

1 followers

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH.